Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharma Industry "Well Positioned" In Current Budget Debate, Avalere's Mendelson Suggests

This article was originally published in The Pink Sheet Daily

Executive Summary

Avalere Health's Dan Mendelson says pharma looks likely to avoid any hits in the budgets being debated for 2011 and 2012, but ideas that would chip away at profits could make a comeback after 2012 elections.

You may also be interested in...



User Fee Waivers For Small Businesses Might Get Smaller Under PDUFA V

FDA wants to tighten its eligibility restrictions for small business waivers of user fees, but industry does not appear interested in changing the rules, even if it would hold down costs for other applicants.

Hamburg Says Generic Drug Reviews Would Slow In Wake Of GOP-Backed Budget Cuts

FDA commissioner predicts poor outlook for medical product review if agency loses appropriations in fiscal 2011 and 2012.

Three Ways IPAB Can Reduce Drug Costs In Medicare: An Interview With Scott Gottlieb

The Independent Payment Advisory Board is likely to take three approaches to reining in drug costs under Medicare, according to American Enterprise Institute Resident Fellow Scott Gottlieb.

Related Content

Topics

UsernamePublicRestriction

Register

GB140150

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel